The following Structured Product Label (SPL) was submitted to the FDA by Energetix Corp for the product Hypothalmapath (NDC 64578-0100). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.
This specific version of the label includes detailed information regarding active ingredients, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.
Gelsemium sempervirens 12X; Ginkgo biloba 6X; Glycyrrhiza glabra 4X; Hydrocotlye asiatica 4X; Hypothalamus 12X; Oleum santali 12X; Petroselinum sativum 4X; Pituitarum posterium 12X; Pyridoxinum hydrochloricum 12X; Senna 8X, 12X; Silicea 12X
* Please review the disclaimer below.
